Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Damiano de Felice chairs panel at 2017 US SIF Annual Conference

On Thursday 11 May, Damiano de Felice chairs the panel ‘Access to Medicine: A Material Issue for Investors in Pharmaceutical Companies’ at the 2017 US SIF Annual Conference in Chicago. US SIF is a leading forum for sustainable and responsible investment in the US. It also addresses impact investing, focusing on investments with a social return.

Date

11 May 2017

Speakers include:

  • Lauren Compere – Managing Director at Boston Common Asset Management,

  • Marshall Gordon – Senior Research Analyst covering the health care sector and Portfolio Manager of the ClearBridge Global Health Care Innovations Strategy –  and

  • Benjamin Tiede – Strategy and Project Management lead for the Global Public Health (GPH) group of Johnson & Johnson.

US SIF is a leading forum for sustainable and responsible investment in the US. It also addresses impact investing, focusing on investments with a social return.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved